Provided by Tiger Trade Technology Pte. Ltd.

Phathom Pharmaceuticals

8.66
-0.2100-2.37%
Post-market: 8.750.0900+1.04%19:30 EDT
Volume:992.80K
Turnover:8.68M
Market Cap:700.60M
PE:-6.84
High:8.92
Open:8.88
Low:8.51
Close:8.87
52wk High:18.31
52wk Low:8.21
Shares:80.90M
Float Shares:63.93M
Volume Ratio:0.94
T/O Rate:1.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2659
EPS(LYR):-3.0342
ROE:-3489.00%
ROA:-8.80%
PB:-2.04
PE(LYR):-2.85

Loading ...

Apr 06, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 01, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 30, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 31, 2020

Major Issues Report

8-K - Current report
Dec 23, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 17, 2020

Major Issues Report

8-K - Current report
Dec 14, 2020

Major Issues Report

8-K - Current report
Nov 30, 2020

Major Issues Report

8-K - Current report
Nov 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2020

Major Issues Report

8-K - Current report
Sep 25, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]